PL2941257T3 - Terapia choroby z zastosowaniem tolerogennego preparatu farmaceutycznego - Google Patents

Terapia choroby z zastosowaniem tolerogennego preparatu farmaceutycznego

Info

Publication number
PL2941257T3
PL2941257T3 PL14700238T PL14700238T PL2941257T3 PL 2941257 T3 PL2941257 T3 PL 2941257T3 PL 14700238 T PL14700238 T PL 14700238T PL 14700238 T PL14700238 T PL 14700238T PL 2941257 T3 PL2941257 T3 PL 2941257T3
Authority
PL
Poland
Prior art keywords
tolerogenic
pharmaceutical preparation
disease therapy
therapy
disease
Prior art date
Application number
PL14700238T
Other languages
English (en)
Inventor
Sylvain PERRUCHE
Philippe SAAS
Francis Bonnefoy
Original Assignee
Institut National De La Santé Et De La Recherche Médicale (Inserm)
Etablissement Français Du Sang
Université de Franche-Comté
Centre Hospitalier Régional Universitaire De Besançon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De La Santé Et De La Recherche Médicale (Inserm), Etablissement Français Du Sang, Université de Franche-Comté, Centre Hospitalier Régional Universitaire De Besançon filed Critical Institut National De La Santé Et De La Recherche Médicale (Inserm)
Publication of PL2941257T3 publication Critical patent/PL2941257T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14700238T 2013-01-07 2014-01-07 Terapia choroby z zastosowaniem tolerogennego preparatu farmaceutycznego PL2941257T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13305009 2013-01-07
PCT/EP2014/050167 WO2014106666A1 (en) 2013-01-07 2014-01-07 Disease therapy using a tolerogenic pharmaceutical preparation
EP14700238.0A EP2941257B1 (en) 2013-01-07 2014-01-07 Disease therapy using a tolerogenic pharmaceutical preparation

Publications (1)

Publication Number Publication Date
PL2941257T3 true PL2941257T3 (pl) 2018-05-30

Family

ID=47559360

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14700238T PL2941257T3 (pl) 2013-01-07 2014-01-07 Terapia choroby z zastosowaniem tolerogennego preparatu farmaceutycznego

Country Status (14)

Country Link
US (2) US10653758B2 (pl)
EP (1) EP2941257B1 (pl)
CY (1) CY1119957T1 (pl)
DK (1) DK2941257T3 (pl)
ES (1) ES2657675T3 (pl)
HR (1) HRP20180359T1 (pl)
HU (1) HUE038211T2 (pl)
LT (1) LT2941257T (pl)
NO (1) NO2941257T3 (pl)
PL (1) PL2941257T3 (pl)
PT (1) PT2941257T (pl)
RS (1) RS56906B1 (pl)
SI (1) SI2941257T1 (pl)
WO (1) WO2014106666A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11000548B2 (en) 2015-02-18 2021-05-11 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
IL303543A (en) 2015-02-18 2023-08-01 Enlivex Therapeutics Rdo Ltd Combined immunotherapy and cytokine control therapy for cancer treatment
US11497767B2 (en) 2015-02-18 2022-11-15 Enlivex Therapeutics R&D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11318163B2 (en) 2015-02-18 2022-05-03 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11596652B2 (en) 2015-02-18 2023-03-07 Enlivex Therapeutics R&D Ltd Early apoptotic cells for use in treating sepsis
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
JP6803339B2 (ja) 2015-04-21 2020-12-23 エンリヴェックス セラピューティクス リミテッド 治療用のプールされた血液アポトーシス細胞調製物及びそれらの使用
KR20180110141A (ko) 2016-02-18 2018-10-08 엔리벡스 테라퓨틱스 리미티드 암을 치료하기 위한 면역요법과 사이토카인 조절 요법의 조합
FR3082730B1 (fr) * 2018-06-21 2022-04-22 Med Inn Pharma Methode de resolution de l'inflammation pro-tumorale a l'aide d'une preparation pharmaceutique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050202098A1 (en) 2001-01-31 2005-09-15 Tolaren Disease therapy using dying or dead cells
WO2006120439A2 (en) * 2005-05-10 2006-11-16 Avaris Ab Cellular vaccine and use thereof
WO2008043018A1 (en) * 2006-10-04 2008-04-10 Dana-Farber Cancer Institute, Inc. Tumor immunity
EP2201954A1 (en) * 2008-12-18 2010-06-30 Aposcience AG Pharmaceutical preparation

Also Published As

Publication number Publication date
DK2941257T3 (en) 2018-02-26
SI2941257T1 (en) 2018-03-30
HRP20180359T1 (hr) 2018-05-04
US20150343039A1 (en) 2015-12-03
US11793865B2 (en) 2023-10-24
CY1119957T1 (el) 2018-12-12
EP2941257A1 (en) 2015-11-11
LT2941257T (lt) 2018-02-26
RS56906B1 (sr) 2018-05-31
EP2941257B1 (en) 2017-11-29
NO2941257T3 (pl) 2018-04-28
ES2657675T3 (es) 2018-03-06
WO2014106666A1 (en) 2014-07-10
PT2941257T (pt) 2018-03-06
US20200237884A1 (en) 2020-07-30
HUE038211T2 (hu) 2018-10-29
US10653758B2 (en) 2020-05-19

Similar Documents

Publication Publication Date Title
IL245211A0 (en) an inhaler for the medicine
RS56906B1 (sr) Terapija za bolest koja koristi tolerogeni farmaceutski preparat
IL243786A0 (en) A drug that contains a pharmaceutical combination of dolutegravir, emtricitabine and tenofovir
HK1214526A1 (zh) 眼底疾病治療劑
ZA201507576B (en) Pharmaceutical combination drug
AP3803A (en) Pharmaceutical dosage form
EP2974730A4 (en) MEDICINES FOR RESPIRATORY DISEASES
AP2015008208A0 (en) Pharmaceutical administration forms comprising
EP3054994A4 (en) Human papilloma virus therapeutic vaccine
HK1223833A1 (zh) 藥物劑型
GB201318686D0 (en) Pharmaceutical preparations
EP2968179A4 (en) RETARD-PRESENTATIONS
ZA201600027B (en) Pharmaceutical preparation
GB201301721D0 (en) Pharmaceutical Preparations
EP2898912A4 (en) INSTRUMENT FOR MEDICINE ADMINISTRATION
HK1216154A1 (zh) 用於外周動脈疾病的藥物遞送裝置
EP2868319A4 (en) ORAL PHARMACEUTICAL PREPARATION OF ARIPIPRAZOLE
EP2949329A4 (en) THERAPEUTIC AGAINST DEMYELINISING DISEASE
ZA201506465B (en) Pharmaceutical preparation
ZA201502354B (en) Pharmaceutical dosage form
GB201309971D0 (en) Oral medicines syringe